FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used to measure concentration of monomeric C-reactive protein on the surface of blood cells. That is ensured by the method of cytofluorometry. Two antibodies to C-reactive protein are used, one of which reacts with epitopes presented only on native C-reactive protein. Second reacts both with epitopes presented on native, and monomer C-reactive proteins. Each antibody is conjugated with a separate cytophluorochrome. Signals obtained from each cytofluorochrome are registered on separate channels simultaneously. A signal from cytofluorochrome conjugated with a selective antibody to native C-reactive protein is recorded. A signal from cytofluorochromes of both antibodies is recorded. A signal from cytofluorochrome conjugated with a cross antibody to the native and monomeric C-reactive protein is recorded. Concentration of monomeric C-reactive protein is calculated based on the obtained data.
EFFECT: invention provides higher effectiveness and sensitivity of the method of measuring monomer C-reactive protein concentration in patients.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR STRATIFICATION OF RESIDUAL INFLAMMATORY RISK OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASES BY THE LEVEL OF MONOMERIC C-REACTIVE PROTEIN | 2021 |
|
RU2764679C1 |
METHOD OF DIAGNOSING IN-STENT RESTENOSIS | 2014 |
|
RU2566287C1 |
MICROVESICLES ORIGINATING FROM CELL PROTOPLASTS AND THEIR USE | 2011 |
|
RU2570636C2 |
SORBENT FOR COMBINED REMOVAL FROM HUMAN PLASMA OF ATHEROGENIC LIPOPROTEIDS AND C-REACTIVE PROTEIN | 2019 |
|
RU2700605C1 |
APPLICATION OF HEPARIN-BINDING ANTAGONISTS IN INHIBITING BRADYKININ RELEASING | 2000 |
|
RU2251433C2 |
RELEASE AND IDENTIFICATION OF T-CELLS | 2003 |
|
RU2327487C2 |
ANTI-CD 16 BINDING MOLECULES | 2006 |
|
RU2491294C2 |
MONOCLONAL ANTIBODIES AGAINST IL-21 OF HUMAN BEING | 2008 |
|
RU2504552C2 |
GENE-CELL VESICULAR THERAPEUTIC DRUG AND METHOD FOR MULTIPLE SCLEROSIS THERAPY BY TRANSPLANTATION OF A GENE-CELL VESICULAR THERAPEUTIC DRUG | 2021 |
|
RU2762855C1 |
METHOD FOR EARLY DIAGNOSIS OF DISEASES BY OPTICAL MEASUREMENT OF NATIVE BIOLOGICAL FLUID PHYSICAL CHARACTERISTICS | 2015 |
|
RU2622761C2 |
Authors
Dates
2019-10-24—Published
2018-08-02—Filed